ArticleScientific reports2026
Synergistic effects of ABCG2 Q141K variant in combination with alcohol consumption and male sex on gout risk in a rare-event Taiwanese cohort.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ABCG2 transporter: Structural and functional associations with gout (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gout is influenced by genetic and lifestyle factors, with ABCG2 variants (rs2231142 Q141K and rs72552713 Q126X) implicated in urate transport and susceptibility. Standard statistical models often yield biased estimates in rare-event cohorts. This cross-sectional study (N = 324, 15 gout cases) used Firth-corrected logistic regression to mitigate small-sample bias and address complete separation in ABCG2 genotyping data. Model performance was evaluated via internal validation with 1000 bootstrap iterations. Q126X was nearly monomorphic (T allele 0.15%), while Q141K showed higher diversity (A allele 28%). Male gender was the strongest predictor (Firth OR 8.1-11.9, P < 0.001), followed by ABCG2 dysfunction (dose-dependent risk, P = 0.055 for severe dysfunction) and alcohol consumption (Firth OR 5.26 for infrequent drinking, P = 0.022). Firth regression successfully corrected upward ML bias (e.g., alcohol OR: 8.30→5.26). The integrated model achieved an apparent AUC of 0.857 and an optimism-corrected AUC of 0.818 via bootstrap validation, demonstrating synergistic effects of genetic, demographic, and lifestyle factors. Robustness was further confirmed by high E-values (e.g., 9.99 for alcohol). These findings illustrate the utility of Firth regression for bias-reduced risk quantification in rare-event studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.